BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv J, Yin H, Mao W, Shi H. Investigating the value of pre-treatment 18F-FDG PET/CT in predicting the pathological characteristic of hepatocellular carcinoma and recurrence after liver transplantation. Abdom Radiol (NY) 2021;46:2490-7. [PMID: 33386905 DOI: 10.1007/s00261-020-02872-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Tu HB, Chen LH, Huang YJ, Feng SY, Lin JL, Zeng YY. Novel model combining contrast-enhanced ultrasound with serology predicts hepatocellular carcinoma recurrence after hepatectomy. World J Clin Cases 2021; 9(24): 7009-7021 [PMID: 34540956 DOI: 10.12998/wjcc.v9.i24.7009] [Reference Citation Analysis]
2 Wu L, Yang C, Halim A, Rao S, Xu P, Feng W, Chen C, Ji Y, Zhu J, Zeng M. Contrast-enhanced magnetic resonance imaging perfusion can predict microvascular invasion in patients with hepatocellular carcinoma (between 1 and 5 cm). Abdom Radiol (NY) 2022. [PMID: 35113174 DOI: 10.1007/s00261-022-03423-6] [Reference Citation Analysis]